Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
46.49%
Operating Margin
13.55%
Net Margin
7.80%
Efficiency Metrics
Revenue per Expense Ratio
1.16
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
30.93%
Income Tax Rate
16.48%
EPS
2.3300000000
Balance Sheet Analysis
Current Ratio
0.84
Cash Ratio
0.00
Working Capital
$-177.00M
Debt to Equity
1.34
Debt to Assets
39.61%
Equity Ratio
29.61%
Cash Flow Analysis
Operating Cash Flow Ratio
14.37%
Free Cash Flow Ratio
-32.09%
CapEx to Revenue
46.46%
Dividends Paid
$179.00M
Stock Buybacks
No buybacks
Total Shareholder Returns
$179.00M
Cash Position Change
-96.97%
Key Takeaways (2023 FY)
Increased dividend payments by 3.48%
Detailed Growth Metrics
Core Performance
Revenue
10.43%
Net Income
-2.15%
EPS
-10.73%
Operating Income
-0.25%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
-50.44%
Operating Cash Flow
-37.69%
Free Cash Flow
-919.57%
Balance Sheet Health
Assets
7.16%
Debt
12.12%
Book Value per Share
9.08%
Inventory
18.95%
Shareholder Returns
Dividends per Share
3.48%
Shares Outstanding
9.49%
Long Term Trends
3Y Revenue/Share
24.74%
5Y Revenue/Share
33.98%
3Y Dividend/Share
17.03%
5Y Dividend/Share
30.68%